Chevy Chase Trust Holdings, Inc. Bristol Myers Squibb CO Transaction History
Chevy Chase Trust Holdings, Inc.
- $33.7 Billion
- Q2 2025
A detailed history of Chevy Chase Trust Holdings, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Chevy Chase Trust Holdings, Inc. holds 1,092,316 shares of BMY stock, worth $50.2 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
1,092,316
Previous 1,081,677
0.98%
Holding current value
$50.2 Million
Previous $66 Million
23.36%
% of portfolio
0.15%
Previous 0.21%
Shares
33 transactions
Others Institutions Holding BMY
# of Institutions
2,730Shares Held
1.59BCall Options Held
26MPut Options Held
24.2M-
Vanguard Group Inc Valley Forge, PA191MShares$8.8 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.3 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.97 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.36 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.06 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $97.8B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...